Skip to Content


Mitchell Stein, quoting Rachel Sachs(Academic Fellow Alumna)
Institute For Clinical And Economic Review
April 6, 2018

Read the Full Article

From the article:

To the shock of patient advocates, MA wanted to institute a drug formulary for Medicaid. Reports this week indicate that CMS is poised to deny the waiver request. Law Professors Nicholas Bagley and Rachel Sachs write in Health Affairs that the supposed reason for the supposed denial makes no sense. Stay tuned!

Read the full weekley view here!

Read the Full Article

Tags

health care finance   medicare-medicaid   pharmaceuticals   rachel sachs